Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Disease Models & Mechanisms|June 8, 2019
Modeling blood diseases with human induced pluripotent stem cellsMaria Georgomanoli, Eirini P PapapetrouHuman Gene Therapy|August 31, 2011
The new self-inactivating lentiviral vector for thalassemia gene therapy combining two HPFH activating elements corrects human thalassemic hematopoietic stem cellsEleni Papanikolaou, Maria Georgomanoli, Evangelos Stamateris, et al.Journal of Visualized Experiments : Jove|August 17, 2023
Murine Dermal Lymphatic Endothelial Cell IsolationRacheal Grace Akwii, Margarita Lamprou, Maria Georgomanoli, et al.Viruses|December 23, 2022
The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34<sup>+</sup> Cells from Sickle Cell Disease PatientsEkati Drakopoulou, Maria Georgomanoli, Carsten W Lederer, et al.Virus Research|April 16, 2013
Characterization and comparative performance of lentiviral vector preparations concentrated by either one-step ultrafiltration or ultracentrifugationEleni Papanikolaou, Georgia Kontostathi, Ekati Drakopoulou, et al.Human Gene Therapy|October 17, 2018
A Novel BaEVRless-Pseudotyped γ-Globin Lentiviral Vector Drives High and Stable Fetal Hemoglobin Expression and Improves Thalassemic Erythropoiesis <i>In Vitro</i>Ekati Drakopoulou, Maria Georgomanoli, Carsten W Lederer, et al.Stem Cell Reports|April 24, 2018
Dissecting the Contributions of Cooperating Gene Mutations to Cancer Phenotypes and Drug Responses with Patient-Derived iPSCsChan-Jung Chang, Andriana G Kotini, Malgorzata Olszewska, et al.Blood|December 16, 2010
Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transferAndrew Wilber, Phillip W Hargrove, Yoon-Sang Kim, et al.Cell Reports|June 4, 2020
Acute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem CellsJosephine Wesely, Andriana G Kotini, Franco Izzo, et al.Pageof 1